Literature DB >> 14990582

Enhanced adhesive capacities of the naturally occurring Ile249-Met280 variant of the chemokine receptor CX3CR1.

Mehdi Daoudi1, Elise Lavergne, Alexandre Garin, Nadine Tarantino, Patrice Debré, Frédéric Pincet, Christophe Combadière, Philippe Deterre.   

Abstract

It was recently shown that individuals carrying the naturally occurring mutant CX3CR1-Ile(249)-Met(280) (hereafter called CX3CR1-IM) have a lower risk of cardiovascular disease than individuals homozygous for the wild-type CX3CR1-Val(249)-Thr(280) (CX3CR1-VT). We report here that peripheral blood mononuclear cells (PBMC) from individuals with the CX3CR1-IM haplotype adhered more potently to membrane-bound CX3CL1 than did PBMC from homozygous CX3CR1-VT donors. Similar excess adhesion was observed with CX3CR1-IM-transfected human embryonic kidney (HEK) cell lines tested with two different methods: the parallel plate laminar flow chamber and the dual pipette aspiration technique. Suppression of the extra adhesion in the presence of pertussis toxin indicates that G-protein mediated the underlying transduction pathway, in contrast to the G-protein-independent adhesion previously described for CX3CR1-VT. Surprisingly, HEK and PBMC that expressed CX3CR1-IM and -VT were indistinguishable when tested with the soluble form of CX3CL1 for chemotaxis, calcium release, and binding capacity. In conclusion, only the membrane-anchored form of CX3CL1 functionally discriminated between these two allelic isoforms of CX3CR1. These results suggest that each form of this ligand may lead to a different signaling pathway. The extra adhesion of CX3CR1-IM may be related to immune defenses and to atherogenesis, both of which depend substantially on adhesive intercellular events.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14990582     DOI: 10.1074/jbc.M313457200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  A natural CCL5/RANTES variant antagonist for CCR1 and CCR3.

Authors:  Corinne Capoulade-Métay; Ahidjo Ayouba; Anfumbom Kfutwah; Kavita Lole; Stéphane Pêtres; Yasmine Dudoit; Philippe Deterre; Elisabeth Menu; Françoise Barré-Sinoussi; Patrice Debré; Ioannis Theodorou
Journal:  Immunogenetics       Date:  2006-06-22       Impact factor: 2.846

2.  Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis.

Authors:  Rachel Nadif; Margaret Mintz; Selma Rivas-Fuentes; Anne Jedlicka; Elise Lavergne; Mathieu Rodero; Francine Kauffmann; Christophe Combadière; Steven R Kleeberger
Journal:  Cytokine       Date:  2006-02-07       Impact factor: 3.861

3.  Functional adhesiveness of the CX3CL1 chemokine requires its aggregation. Role of the transmembrane domain.

Authors:  Patricia Hermand; Frédéric Pincet; Stéphanie Carvalho; Hervé Ansanay; Eric Trinquet; Mehdi Daoudi; Christophe Combadière; Philippe Deterre
Journal:  J Biol Chem       Date:  2008-08-25       Impact factor: 5.157

Review 4.  Coronary heart disease and polymorphisms in genes affecting lipid metabolism and inflammation.

Authors:  François Cambien
Journal:  Curr Atheroscler Rep       Date:  2005-05       Impact factor: 5.113

5.  A role for Rho GTPases and cell-cell adhesion in single-cell motility in vivo.

Authors:  Elena Kardash; Michal Reichman-Fried; Jean-Léon Maître; Bijan Boldajipour; Ekaterina Papusheva; Esther-Maria Messerschmidt; Carl-Philipp Heisenberg; Erez Raz
Journal:  Nat Cell Biol       Date:  2009-12-13       Impact factor: 28.824

6.  Common polymorphisms of chemokine (C-X3-C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population-based study.

Authors:  Andrea Calvo; Cristina Moglia; Antonio Canosa; Stefania Cammarosano; Antonio Ilardi; Davide Bertuzzo; Bryan J Traynor; Maura Brunetti; Marco Barberis; Gabriele Mora; Federico Casale; Adriano Chiò
Journal:  Muscle Nerve       Date:  2017-04-25       Impact factor: 3.217

7.  Association of the CX3CR1-V249I Variant with Neurofibrillary Pathology Progression in Late-Onset Alzheimer's Disease.

Authors:  Alan López-López; Ellen Gelpi; Diana Maria Lopategui; Jose M Vidal-Taboada
Journal:  Mol Neurobiol       Date:  2017-03-25       Impact factor: 5.590

8.  The homozygous CX3CR1-M280 mutation impairs human monocyte survival.

Authors:  Amanda L Collar; Muthulekha Swamydas; Morgan O'Hayre; Md Sanaullah Sajib; Kevin W Hoffman; Satya P Singh; Ahmad Mourad; Melissa D Johnson; Elise Mn Ferre; Joshua M Farber; Jean K Lim; Constantinos M Mikelis; J Silvio Gutkind; Michail S Lionakis
Journal:  JCI Insight       Date:  2018-02-08

Review 9.  Regulation of atherogenesis by chemokines and chemokine receptors.

Authors:  Wuzhou Wan; Philip M Murphy
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2012-12-07       Impact factor: 4.291

10.  Search for an association between V249I and T280M CX3CR1 genetic polymorphisms, endothelial injury and preeclampsia: the ECLAXIR study.

Authors:  Alain Stepanian; Soraya Benchenni; Tiphaine Beillat-Lucas; Sophie Omnes; Fannie Defay; Edith Peynaud-Debayle; Gabriel Baron; Agnès Le Querrec; Michel Dreyfus; Laurence Salomon; Vassilis Tsatsaris; Dominique de Prost; Laurent Mandelbrot
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.